Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Finasteride may cause floppy-iris syndrome during cataract surgery, so check patients' medical history.

Endocrine disruptors may cause early hair loss.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Different genes are linked to various types of hair loss.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Baicalin may help reduce excessive male hormone levels in PCOS.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Birth control pills can improve or cause acne and hair issues, with improvements more common, and may affect skin pigmentation.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Birth control pills help treat acne, especially when caused by excess male hormones, and are safe to use with antibiotics.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.